Canaccord Genuity maintains a 'Buy' on Palomar Medical Technologies (NASDAQ: PMTI), lowers PT from $13.25 to $13.

Canaccord analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE